Axa
FOMX

Axa’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Axa’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,304,424
Closed -$4.34M – 1294
2019
Q4 		$4.34M Hold
1,304,424
– – 0.02% 663
2019
Q3 		$3.96M Sell
1,304,424
-39,838
-3% -$112K 0.02% 716
2019
Q2 		$3.2M Sell
1,344,262
-6,676
-0.5% -$19.9K 0.01% 770
2019
Q1 		$5.07M Hold
1,350,938
– – 0.02% 642
2018
Q4 		$4.85M Sell
1,350,938
-18,403
-1% -$80K 0.02% 612
2018
Q3 		$7.85M Buy
1,369,341
+416,787
+44% +$2.38M 0.03% 540
2018
Q2 		$4.77M Hold
952,554
– – 0.02% 667
2018
Q1 		$4.89M Hold
952,554
– – 0.02% 661
2017
Q4 		$5.72M Buy
952,554
+9,819
+1% +$59.1K 0.02% 614
2017
Q3 		$5.23M Hold
942,735
– – 0.02% 612
2017
Q2 		$4.37M Buy
942,735
+116,298
+14% +$519K 0.02% 636
2017
Q1 		$4.09M Buy
826,437
+133,602
+19% +$1.29M 0.02% 634
2016
Q4 		$7.69M Hold
692,835
– – 0.04% 476
2016
Q3 		$6.42M Buy
+692,835
New +$5.79M 0.03% 518

Axa's FOMX Position: Q1 2020 in Review

Axa sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 1,304,424 shares — an estimated $4.34M sold.

Axa first reported a position in FOMX in Q3 2016 and held it in 14 quarters. The position peaked at $7.85M in Q3 2018. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • Axa reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • Axa sold 1,304,424 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $4.34M.
  • Axa first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2016 and held it in 14 quarters.
  • Axa's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $7.85M in Q3 2018.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Axa's 13F filing for Q1 2020, filed 15 May 2020.